Study in Scientific Reports finds no ‘optimal’ balance between solitude and socializing for mental health, suggesting that individual preferences and motivations play a crucial role in well-being.
Eisai heads to FDA with subcutaneous version of Alzheimer’s treatment developed with Biogen
Eisai and Biogen said Tuesday that they started an application for an under-the-skin maintenance dosing version of their Alzheimer’s treatment Leqembi. The subcutaneous submission was